Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3644008
Max Phase: Preclinical
Molecular Formula: C21H28N4O2
Molecular Weight: 368.48
Molecule Type: Small molecule
Associated Items:
ID: ALA3644008
Max Phase: Preclinical
Molecular Formula: C21H28N4O2
Molecular Weight: 368.48
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: C[C@@H]1CN(c2ccc(-c3cccc(CN(C)C(=O)CN)c3)cn2)C[C@H](C)O1
Standard InChI: InChI=1S/C21H28N4O2/c1-15-12-25(13-16(2)27-15)20-8-7-19(11-23-20)18-6-4-5-17(9-18)14-24(3)21(26)10-22/h4-9,11,15-16H,10,12-14,22H2,1-3H3/t15-,16+
Standard InChI Key: LXVCULZUKZONSR-IYBDPMFKSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 368.48 | Molecular Weight (Monoisotopic): 368.2212 | AlogP: 2.28 | #Rotatable Bonds: 5 |
Polar Surface Area: 71.69 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 8.13 | CX LogP: 1.96 | CX LogD: 1.15 |
Aromatic Rings: 2 | Heavy Atoms: 27 | QED Weighted: 0.88 | Np Likeness Score: -1.60 |
1. (2014) Glycine compound, |
Source(1):